Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. (Q48467853)

11 February 2018

title

Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. (English)

1 reference

11 February 2018

main subject

Guillain–Barré syndrome

0 references

author name string

Ilyas AA

1

1 reference

11 February 2018

Cook SD

2

1 reference

11 February 2018

Mithen FA

3

1 reference

11 February 2018

Taki T

4

1 reference

11 February 2018

Kasama T

5

1 reference

11 February 2018

Handa S

6

1 reference

11 February 2018

Hamasaki H

7

1 reference

11 February 2018

Singhal BS

8

1 reference

11 February 2018

Li SC

9

1 reference

11 February 2018

Li YT

10

1 reference

11 February 2018

publication date

1 March 1998

1 reference

11 February 2018

Journal of Neuroimmunology

published in

1 reference

11 February 2018

volume

82

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

160-167

1 reference

11 February 2018

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Improved method for large-scale purification of brain gangliosides by Q-sepharose column chromatography. Immunochemical detection of C-series polysialogangliosides in adult bovine brains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Controlled trial prednisolone in acute polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Identification and characterization of gangliosides reacting with IgM paraproteins in three patients with neuropathy associated with biclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Serum antibodies to gangliosides in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Antibodies to sulfated glycolipids in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Anti-GM1 IgA antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Multifocal motor neuropathy human sera block distal motor nerve conduction in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Blotting of glycolipids and phospholipids from a high-performance thin-layer chromatogram to a polyvinylidene difluoride membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Direct mass spectrometric analysis of glycosphingolipid transferred to a polyvinylidene difluoride membrane by thin-layer chromatography blotting

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Anti-GM1 antibodies in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900197-5

7 January 2021

10.1016/S0165-5728(97)00197-5

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9585812

1 reference

11 February 2018